HealthDay (4/1, Goodwin) reported that, according to a study presented at a laser medicine conference, cryoneuromodulation, “a new technology that temporarily zaps away forehead wrinkles by freezing the nerves, shows promise in early clinical trials.” HealthDay added, “The technique, if eventually approved by the US Food and Drug Administration, could provide an alternative to Botox [onabotulinumtoxin A] and Dysport [abobotulinumtoxin A]. Both are injectable forms of Botulinum toxin type A, a neurotoxin that, when injected in small quantities, temporarily paralyzes facial muscles, thereby reducing wrinkles,” HealthDay noted.
In “Patient Money,” the New York Times (4/2, B5, Andrews) discusses presbyopia, a condition that occurs when the “lens of the eye becomes harder and less elastic,” resulting in “a gradual worsening of the ability to focus on objects up close” for those over 40. Having presbyopia is “‘like having a camera with no multifocal option,’ said Dr. Rachel J. Bishop, chief of the consult services section of the National Eye Institute.” The article explains various options for correcting the condition, including reading glasses, bifocal or multi-focal contact lenses, and progressive bifocals. The New York Times (4/1, Parker-Pope) “Well” blog also covered the story.